TICKER INTELLIGENCE
$GNRC is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 3 active Congressional signals mentioning $GNRC, including 3 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
$GNRC is currently facing 3 active congressional signals tracked by HillSignal. With 3 bullish, and 0 bearish signals, the average legislative impact score is 5.3/10. Key sectors affected include Healthcare, Manufacturing and Consumer. Recent major catalysts include HEAR Act of 2025 and Hearing Device Coverage Clarification Act. Below is the complete tracker of government activity affecting $GNRC’s market performance.
3
Total Signals
5.3/10
Avg Impact
3
Bullish Signals
0
Bearish Signals
The HEAR Act of 2025 mandates Medicare coverage for hearing aids and related rehabilitation services, directly expanding the market for hearing device manufacturers and audiology service providers. This legislation creates a new revenue stream for companies in the hearing health sector by bringing Medicare beneficiaries into the market.
The Veterans Hearing Aid Improvement Act of 2026 establishes a two-year demonstration project for VA coverage of over-the-counter (OTC) hearing aids for veterans with mild-to-moderate hearing loss. This creates a new procurement channel for OTC hearing aid manufacturers and retailers, expanding market access within the VA system. The bill directly benefits companies involved in OTC hearing aid production and distribution.
The Hearing Device Coverage Clarification Act, HR1921, clarifies Medicare coverage for hearing aids, expanding the market for hearing device manufacturers and retailers. This bill directly increases demand for hearing-related products and services, benefiting companies in the hearing aid sector.
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Become a Member →